Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:ighv4-34 positive'
(id=10041982 ; fe=en:ighv4-34 positive ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2677 creation date=2018-02-24 touchdate=2025-11-03 06:12:37.000)
≈ 103 relations sortantes

  1. en:ighv4-34 positive -- r_associated #0: 41 / 1 -> en:fgfr2 positive
    n1=en:ighv4-34 positive | n2=en:fgfr2 positive | rel=r_associated | relid=0 | w=41
  2. en:ighv4-34 positive -- r_associated #0: 41 / 1 -> en:ganglioside gd2 positive
    n1=en:ighv4-34 positive | n2=en:ganglioside gd2 positive | rel=r_associated | relid=0 | w=41
  3. en:ighv4-34 positive -- r_associated #0: 41 / 1 -> en:hla-cw*0702 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-cw*0702 positive cells present | rel=r_associated | relid=0 | w=41
  4. en:ighv4-34 positive -- r_associated #0: 37 / 0.902 -> en:hla-a1 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a1 positive cells present | rel=r_associated | relid=0 | w=37
  5. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:alk gene alteration positive
    n1=en:ighv4-34 positive | n2=en:alk gene alteration positive | rel=r_associated | relid=0 | w=35
  6. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:hla class i histocompatibility antigen, a-0201 alpha chain positive
    n1=en:ighv4-34 positive | n2=en:hla class i histocompatibility antigen, a-0201 alpha chain positive | rel=r_associated | relid=0 | w=35
  7. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:human papillomavirus positive
    n1=en:ighv4-34 positive | n2=en:human papillomavirus positive | rel=r_associated | relid=0 | w=35
  8. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:magea6 positive
    n1=en:ighv4-34 positive | n2=en:magea6 positive | rel=r_associated | relid=0 | w=35
  9. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:myc positive
    n1=en:ighv4-34 positive | n2=en:myc positive | rel=r_associated | relid=0 | w=35
  10. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:nectin4 positive
    n1=en:ighv4-34 positive | n2=en:nectin4 positive | rel=r_associated | relid=0 | w=35
  11. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:positive blood culture
    n1=en:ighv4-34 positive | n2=en:positive blood culture | rel=r_associated | relid=0 | w=35
  12. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:ptprc positive
    n1=en:ighv4-34 positive | n2=en:ptprc positive | rel=r_associated | relid=0 | w=35
  13. en:ighv4-34 positive -- r_associated #0: 35 / 0.854 -> en:tnfrsf17 positive
    n1=en:ighv4-34 positive | n2=en:tnfrsf17 positive | rel=r_associated | relid=0 | w=35
  14. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:cd11c positive
    n1=en:ighv4-34 positive | n2=en:cd11c positive | rel=r_associated | relid=0 | w=34
  15. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:cd33 positive
    n1=en:ighv4-34 positive | n2=en:cd33 positive | rel=r_associated | relid=0 | w=34
  16. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:cdkn2a-p16 positive
    n1=en:ighv4-34 positive | n2=en:cdkn2a-p16 positive | rel=r_associated | relid=0 | w=34
  17. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:gpc3 positive
    n1=en:ighv4-34 positive | n2=en:gpc3 positive | rel=r_associated | relid=0 | w=34
  18. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:hla-a24 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a24 positive cells present | rel=r_associated | relid=0 | w=34
  19. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:magea3 positive
    n1=en:ighv4-34 positive | n2=en:magea3 positive | rel=r_associated | relid=0 | w=34
  20. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:monoclonal cellular population present
    n1=en:ighv4-34 positive | n2=en:monoclonal cellular population present | rel=r_associated | relid=0 | w=34
  21. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:ntrk1 fusion positive
    n1=en:ighv4-34 positive | n2=en:ntrk1 fusion positive | rel=r_associated | relid=0 | w=34
  22. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:ntrk1 gene alteration positive
    n1=en:ighv4-34 positive | n2=en:ntrk1 gene alteration positive | rel=r_associated | relid=0 | w=34
  23. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:ntrk3 gene alteration positive
    n1=en:ighv4-34 positive | n2=en:ntrk3 gene alteration positive | rel=r_associated | relid=0 | w=34
  24. en:ighv4-34 positive -- r_associated #0: 34 / 0.829 -> en:positive lymph node
    n1=en:ighv4-34 positive | n2=en:positive lymph node | rel=r_associated | relid=0 | w=34
  25. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:alk positive
    n1=en:ighv4-34 positive | n2=en:alk positive | rel=r_associated | relid=0 | w=32
  26. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:ar-v7 positive
    n1=en:ighv4-34 positive | n2=en:ar-v7 positive | rel=r_associated | relid=0 | w=32
  27. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:cd22 positive
    n1=en:ighv4-34 positive | n2=en:cd22 positive | rel=r_associated | relid=0 | w=32
  28. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:hla-a2 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a2 positive cells present | rel=r_associated | relid=0 | w=32
  29. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:kdr positive
    n1=en:ighv4-34 positive | n2=en:kdr positive | rel=r_associated | relid=0 | w=32
  30. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:lypd3 positive
    n1=en:ighv4-34 positive | n2=en:lypd3 positive | rel=r_associated | relid=0 | w=32
  31. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:positive immunophenotypic test result
    n1=en:ighv4-34 positive | n2=en:positive immunophenotypic test result | rel=r_associated | relid=0 | w=32
  32. en:ighv4-34 positive -- r_associated #0: 32 / 0.78 -> en:runx1/runx1t1 fusion positive
    n1=en:ighv4-34 positive | n2=en:runx1/runx1t1 fusion positive | rel=r_associated | relid=0 | w=32
  33. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:bcl2 positive
    n1=en:ighv4-34 positive | n2=en:bcl2 positive | rel=r_associated | relid=0 | w=31
  34. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:bcl6 positive
    n1=en:ighv4-34 positive | n2=en:bcl6 positive | rel=r_associated | relid=0 | w=31
  35. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:cd19 positive
    n1=en:ighv4-34 positive | n2=en:cd19 positive | rel=r_associated | relid=0 | w=31
  36. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:cytomegalovirus positive
    n1=en:ighv4-34 positive | n2=en:cytomegalovirus positive | rel=r_associated | relid=0 | w=31
  37. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:hepatitis c virus positive
    n1=en:ighv4-34 positive | n2=en:hepatitis c virus positive | rel=r_associated | relid=0 | w=31
  38. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:hla-a3/a11 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a3/a11 positive cells present | rel=r_associated | relid=0 | w=31
  39. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:jak2 fusion positive
    n1=en:ighv4-34 positive | n2=en:jak2 fusion positive | rel=r_associated | relid=0 | w=31
  40. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:ntrk2 fusion positive
    n1=en:ighv4-34 positive | n2=en:ntrk2 fusion positive | rel=r_associated | relid=0 | w=31
  41. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:somatostatin receptor positive
    n1=en:ighv4-34 positive | n2=en:somatostatin receptor positive | rel=r_associated | relid=0 | w=31
  42. en:ighv4-34 positive -- r_associated #0: 31 / 0.756 -> en:tyrosinase positive
    n1=en:ighv4-34 positive | n2=en:tyrosinase positive | rel=r_associated | relid=0 | w=31
  43. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:cd2 positive
    n1=en:ighv4-34 positive | n2=en:cd2 positive | rel=r_associated | relid=0 | w=30
  44. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:eso-1 positive cells present
    n1=en:ighv4-34 positive | n2=en:eso-1 positive cells present | rel=r_associated | relid=0 | w=30
  45. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:fcer2 positive
    n1=en:ighv4-34 positive | n2=en:fcer2 positive | rel=r_associated | relid=0 | w=30
  46. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:gli1 positive
    n1=en:ighv4-34 positive | n2=en:gli1 positive | rel=r_associated | relid=0 | w=30
  47. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:hla-dpb1*04 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-dpb1*04 positive cells present | rel=r_associated | relid=0 | w=30
  48. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:interleukin-3 receptor subunit alpha positive
    n1=en:ighv4-34 positive | n2=en:interleukin-3 receptor subunit alpha positive | rel=r_associated | relid=0 | w=30
  49. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:met positive
    n1=en:ighv4-34 positive | n2=en:met positive | rel=r_associated | relid=0 | w=30
  50. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:prame positive
    n1=en:ighv4-34 positive | n2=en:prame positive | rel=r_associated | relid=0 | w=30
  51. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:rb1 positive
    n1=en:ighv4-34 positive | n2=en:rb1 positive | rel=r_associated | relid=0 | w=30
  52. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:ros1 gene alteration positive
    n1=en:ighv4-34 positive | n2=en:ros1 gene alteration positive | rel=r_associated | relid=0 | w=30
  53. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:tnfrsf8 positive
    n1=en:ighv4-34 positive | n2=en:tnfrsf8 positive | rel=r_associated | relid=0 | w=30
  54. en:ighv4-34 positive -- r_associated #0: 30 / 0.732 -> en:wnt positive
    n1=en:ighv4-34 positive | n2=en:wnt positive | rel=r_associated | relid=0 | w=30
  55. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:carcinoembryonic antigen positive
    n1=en:ighv4-34 positive | n2=en:carcinoembryonic antigen positive | rel=r_associated | relid=0 | w=29
  56. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:ccnd1 positive
    n1=en:ighv4-34 positive | n2=en:ccnd1 positive | rel=r_associated | relid=0 | w=29
  57. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:cd3 positive
    n1=en:ighv4-34 positive | n2=en:cd3 positive | rel=r_associated | relid=0 | w=29
  58. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:cd70 positive
    n1=en:ighv4-34 positive | n2=en:cd70 positive | rel=r_associated | relid=0 | w=29
  59. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:cd79b positive
    n1=en:ighv4-34 positive | n2=en:cd79b positive | rel=r_associated | relid=0 | w=29
  60. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:ctrp disease terminology
    n1=en:ighv4-34 positive | n2=en:ctrp disease terminology | rel=r_associated | relid=0 | w=29
  61. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:hla-a11 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a11 positive cells present | rel=r_associated | relid=0 | w=29
  62. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:latent membrane protein 1 positive
    n1=en:ighv4-34 positive | n2=en:latent membrane protein 1 positive | rel=r_associated | relid=0 | w=29
  63. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:magea10 positive
    n1=en:ighv4-34 positive | n2=en:magea10 positive | rel=r_associated | relid=0 | w=29
  64. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:mycn positive
    n1=en:ighv4-34 positive | n2=en:mycn positive | rel=r_associated | relid=0 | w=29
  65. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:ntrk2 gene alteration positive
    n1=en:ighv4-34 positive | n2=en:ntrk2 gene alteration positive | rel=r_associated | relid=0 | w=29
  66. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:positive surgical margin
    n1=en:ighv4-34 positive | n2=en:positive surgical margin | rel=r_associated | relid=0 | w=29
  67. en:ighv4-34 positive -- r_associated #0: 29 / 0.707 -> en:ret fusion positive
    n1=en:ighv4-34 positive | n2=en:ret fusion positive | rel=r_associated | relid=0 | w=29
  68. en:ighv4-34 positive -- r_associated #0: 28 / 0.683 -> en:anti-nuclear factor positive
    n1=en:ighv4-34 positive | n2=en:anti-nuclear factor positive | rel=r_associated | relid=0 | w=28
  69. en:ighv4-34 positive -- r_associated #0: 28 / 0.683 -> en:fgfr family alteration positive
    n1=en:ighv4-34 positive | n2=en:fgfr family alteration positive | rel=r_associated | relid=0 | w=28
  70. en:ighv4-34 positive -- r_associated #0: 28 / 0.683 -> en:ntrk3 fusion positive
    n1=en:ighv4-34 positive | n2=en:ntrk3 fusion positive | rel=r_associated | relid=0 | w=28
  71. en:ighv4-34 positive -- r_associated #0: 28 / 0.683 -> en:tfe3 positive
    n1=en:ighv4-34 positive | n2=en:tfe3 positive | rel=r_associated | relid=0 | w=28
  72. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:cd276 antigen positive
    n1=en:ighv4-34 positive | n2=en:cd276 antigen positive | rel=r_associated | relid=0 | w=27
  73. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:cd5 positive
    n1=en:ighv4-34 positive | n2=en:cd5 positive | rel=r_associated | relid=0 | w=27
  74. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:crlf2 positive
    n1=en:ighv4-34 positive | n2=en:crlf2 positive | rel=r_associated | relid=0 | w=27
  75. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:epstein-barr virus positive
    n1=en:ighv4-34 positive | n2=en:epstein-barr virus positive | rel=r_associated | relid=0 | w=27
  76. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:fgf family alteration positive
    n1=en:ighv4-34 positive | n2=en:fgf family alteration positive | rel=r_associated | relid=0 | w=27
  77. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:folate receptor alpha positive
    n1=en:ighv4-34 positive | n2=en:folate receptor alpha positive | rel=r_associated | relid=0 | w=27
  78. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:hla-a3 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a3 positive cells present | rel=r_associated | relid=0 | w=27
  79. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:il13ra2 positive
    n1=en:ighv4-34 positive | n2=en:il13ra2 positive | rel=r_associated | relid=0 | w=27
  80. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:met fusion gene positive
    n1=en:ighv4-34 positive | n2=en:met fusion gene positive | rel=r_associated | relid=0 | w=27
  81. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:ncam1 positive
    n1=en:ighv4-34 positive | n2=en:ncam1 positive | rel=r_associated | relid=0 | w=27
  82. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:pdgfra positive
    n1=en:ighv4-34 positive | n2=en:pdgfra positive | rel=r_associated | relid=0 | w=27
  83. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:pml/rara fusion positive
    n1=en:ighv4-34 positive | n2=en:pml/rara fusion positive | rel=r_associated | relid=0 | w=27
  84. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:ros1 fusion positive
    n1=en:ighv4-34 positive | n2=en:ros1 fusion positive | rel=r_associated | relid=0 | w=27
  85. en:ighv4-34 positive -- r_associated #0: 27 / 0.659 -> en:survivin positive
    n1=en:ighv4-34 positive | n2=en:survivin positive | rel=r_associated | relid=0 | w=27
  86. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:cdh3 positive
    n1=en:ighv4-34 positive | n2=en:cdh3 positive | rel=r_associated | relid=0 | w=26
  87. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:coombs test positive
    n1=en:ighv4-34 positive | n2=en:coombs test positive | rel=r_associated | relid=0 | w=26
  88. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:egfr positive
    n1=en:ighv4-34 positive | n2=en:egfr positive | rel=r_associated | relid=0 | w=26
  89. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:epstein-barr virus early rna positive
    n1=en:ighv4-34 positive | n2=en:epstein-barr virus early rna positive | rel=r_associated | relid=0 | w=26
  90. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:hla-a31 positive cells present
    n1=en:ighv4-34 positive | n2=en:hla-a31 positive cells present | rel=r_associated | relid=0 | w=26
  91. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:mesothelin positive
    n1=en:ighv4-34 positive | n2=en:mesothelin positive | rel=r_associated | relid=0 | w=26
  92. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:mlana positive
    n1=en:ighv4-34 positive | n2=en:mlana positive | rel=r_associated | relid=0 | w=26
  93. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:nr3c1 positive
    n1=en:ighv4-34 positive | n2=en:nr3c1 positive | rel=r_associated | relid=0 | w=26
  94. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:ny-eso-1 positive tumor cells present
    n1=en:ighv4-34 positive | n2=en:ny-eso-1 positive tumor cells present | rel=r_associated | relid=0 | w=26
  95. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:positive herpes simplex virus culture
    n1=en:ighv4-34 positive | n2=en:positive herpes simplex virus culture | rel=r_associated | relid=0 | w=26
  96. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:positive pseudomonas culture
    n1=en:ighv4-34 positive | n2=en:positive pseudomonas culture | rel=r_associated | relid=0 | w=26
  97. en:ighv4-34 positive -- r_associated #0: 26 / 0.634 -> en:wt1 positive
    n1=en:ighv4-34 positive | n2=en:wt1 positive | rel=r_associated | relid=0 | w=26
  98. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:ag7 antigen positive
    n1=en:ighv4-34 positive | n2=en:ag7 antigen positive | rel=r_associated | relid=0 | w=20
  99. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:ccnd2 positive
    n1=en:ighv4-34 positive | n2=en:ccnd2 positive | rel=r_associated | relid=0 | w=20
  100. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:cd38 positive
    n1=en:ighv4-34 positive | n2=en:cd38 positive | rel=r_associated | relid=0 | w=20
  101. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:cox2 positive
    n1=en:ighv4-34 positive | n2=en:cox2 positive | rel=r_associated | relid=0 | w=20
  102. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:egfr gene alteration positive
    n1=en:ighv4-34 positive | n2=en:egfr gene alteration positive | rel=r_associated | relid=0 | w=20
  103. en:ighv4-34 positive -- r_associated #0: 20 / 0.488 -> en:ighv4-34 gene
    n1=en:ighv4-34 positive | n2=en:ighv4-34 gene | rel=r_associated | relid=0 | w=20
≈ 104 relations entrantes

  1. en:egfr gene alteration positive --- r_associated #0: 42 --> en:ighv4-34 positive
    n1=en:egfr gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=42
  2. en:ros1 gene alteration positive --- r_associated #0: 42 --> en:ighv4-34 positive
    n1=en:ros1 gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=42
  3. en:cytomegalovirus positive --- r_associated #0: 40 --> en:ighv4-34 positive
    n1=en:cytomegalovirus positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=40
  4. en:bcl2 positive --- r_associated #0: 37 --> en:ighv4-34 positive
    n1=en:bcl2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=37
  5. en:cd276 antigen positive --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:cd276 antigen positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  6. en:cd5 positive --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:cd5 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  7. en:hla-a11 positive cells present --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:hla-a11 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  8. en:magea3 positive --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:magea3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  9. en:survivin positive --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:survivin positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  10. en:tfe3 positive --- r_associated #0: 35 --> en:ighv4-34 positive
    n1=en:tfe3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=35
  11. en:bcl6 positive --- r_associated #0: 34 --> en:ighv4-34 positive
    n1=en:bcl6 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=34
  12. en:cdh3 positive --- r_associated #0: 34 --> en:ighv4-34 positive
    n1=en:cdh3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=34
  13. en:ntrk2 fusion positive --- r_associated #0: 34 --> en:ighv4-34 positive
    n1=en:ntrk2 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=34
  14. en:ny-eso-1 positive tumor cells present --- r_associated #0: 34 --> en:ighv4-34 positive
    n1=en:ny-eso-1 positive tumor cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=34
  15. en:cd11c positive --- r_associated #0: 32 --> en:ighv4-34 positive
    n1=en:cd11c positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=32
  16. en:fgf family alteration positive --- r_associated #0: 32 --> en:ighv4-34 positive
    n1=en:fgf family alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=32
  17. en:ighv4-34 gene --- r_associated #0: 32 --> en:ighv4-34 positive
    n1=en:ighv4-34 gene | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=32
  18. en:jak2 fusion positive --- r_associated #0: 32 --> en:ighv4-34 positive
    n1=en:jak2 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=32
  19. en:nr3c1 positive --- r_associated #0: 32 --> en:ighv4-34 positive
    n1=en:nr3c1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=32
  20. en:cd22 positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:cd22 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  21. en:cox2 positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:cox2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  22. en:il13ra2 positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:il13ra2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  23. en:lypd3 positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:lypd3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  24. en:magea10 positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:magea10 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  25. en:ret fusion positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:ret fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  26. en:ros1 fusion positive --- r_associated #0: 31 --> en:ighv4-34 positive
    n1=en:ros1 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=31
  27. en:cd2 positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:cd2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  28. en:cd33 positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:cd33 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  29. en:cd38 positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:cd38 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  30. en:cd70 positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:cd70 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  31. en:interleukin-3 receptor subunit alpha positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:interleukin-3 receptor subunit alpha positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  32. en:mycn positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:mycn positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  33. en:nectin4 positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:nectin4 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  34. en:ntrk3 gene alteration positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:ntrk3 gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  35. en:ptprc positive --- r_associated #0: 30 --> en:ighv4-34 positive
    n1=en:ptprc positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=30
  36. en:ccnd2 positive --- r_associated #0: 29 --> en:ighv4-34 positive
    n1=en:ccnd2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  37. en:egfr positive --- r_associated #0: 29 --> en:ighv4-34 positive
    n1=en:egfr positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  38. en:myc positive --- r_associated #0: 29 --> en:ighv4-34 positive
    n1=en:myc positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  39. en:ntrk2 gene alteration positive --- r_associated #0: 29 --> en:ighv4-34 positive
    n1=en:ntrk2 gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  40. en:prame positive --- r_associated #0: 29 --> en:ighv4-34 positive
    n1=en:prame positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=29
  41. en:ag7 antigen positive --- r_associated #0: 28 --> en:ighv4-34 positive
    n1=en:ag7 antigen positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=28
  42. en:magea6 positive --- r_associated #0: 28 --> en:ighv4-34 positive
    n1=en:magea6 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=28
  43. en:ntrk1 gene alteration positive --- r_associated #0: 28 --> en:ighv4-34 positive
    n1=en:ntrk1 gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=28
  44. en:alk gene alteration positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:alk gene alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  45. en:cd79b positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:cd79b positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  46. en:gli1 positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:gli1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  47. en:gpc3 positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:gpc3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  48. en:met positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:met positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  49. en:ntrk3 fusion positive --- r_associated #0: 27 --> en:ighv4-34 positive
    n1=en:ntrk3 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=27
  50. en:ar-v7 positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:ar-v7 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  51. en:cd3 positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:cd3 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  52. en:crlf2 positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:crlf2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  53. en:fgfr family alteration positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:fgfr family alteration positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  54. en:met fusion gene positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:met fusion gene positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  55. en:mlana positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:mlana positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  56. en:ntrk1 fusion positive --- r_associated #0: 26 --> en:ighv4-34 positive
    n1=en:ntrk1 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=26
  57. en:alk positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:alk positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  58. en:anti-nuclear factor positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:anti-nuclear factor positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  59. en:carcinoembryonic antigen positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:carcinoembryonic antigen positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  60. en:ccnd1 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:ccnd1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  61. en:cd19 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:cd19 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  62. en:cdkn2a-p16 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:cdkn2a-p16 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  63. en:coombs test positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:coombs test positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  64. en:ctrp disease terminology --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:ctrp disease terminology | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  65. en:epstein-barr virus early rna positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:epstein-barr virus early rna positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  66. en:epstein-barr virus positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:epstein-barr virus positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  67. en:eso-1 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:eso-1 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  68. en:fcer2 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:fcer2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  69. en:fgfr2 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:fgfr2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  70. en:folate receptor alpha positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:folate receptor alpha positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  71. en:ganglioside gd2 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:ganglioside gd2 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  72. en:hepatitis c virus positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hepatitis c virus positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  73. en:hla class i histocompatibility antigen, a-0201 alpha chain positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla class i histocompatibility antigen, a-0201 alpha chain positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  74. en:hla-a1 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a1 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  75. en:hla-a2 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a2 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  76. en:hla-a24 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a24 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  77. en:hla-a3 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a3 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  78. en:hla-a3/a11 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a3/a11 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  79. en:hla-a31 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-a31 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  80. en:hla-cw*0702 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-cw*0702 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  81. en:hla-dpb1*04 positive cells present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:hla-dpb1*04 positive cells present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  82. en:human papillomavirus positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:human papillomavirus positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  83. en:kdr positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:kdr positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  84. en:latent membrane protein 1 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:latent membrane protein 1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  85. en:mesothelin positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:mesothelin positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  86. en:monoclonal cellular population present --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:monoclonal cellular population present | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  87. en:ncam1 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:ncam1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  88. en:pdgfra positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:pdgfra positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  89. en:pml/rara fusion positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:pml/rara fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  90. en:positive blood culture --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive blood culture | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  91. en:positive herpes simplex virus culture --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive herpes simplex virus culture | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  92. en:positive immunophenotypic test result --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive immunophenotypic test result | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  93. en:positive lymph node --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive lymph node | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  94. en:positive pseudomonas culture --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive pseudomonas culture | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  95. en:positive surgical margin --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:positive surgical margin | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  96. en:rb1 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:rb1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  97. en:runx1/runx1t1 fusion positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:runx1/runx1t1 fusion positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  98. en:somatostatin receptor positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:somatostatin receptor positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  99. en:tnfrsf17 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:tnfrsf17 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  100. en:tnfrsf8 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:tnfrsf8 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  101. en:tyrosinase positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:tyrosinase positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  102. en:wnt positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:wnt positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  103. en:wt1 positive --- r_associated #0: 20 --> en:ighv4-34 positive
    n1=en:wt1 positive | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=20
  104. présence de cellules tumorales positives pour NY-ESO-1 --- r_associated #0: 10 --> en:ighv4-34 positive
    n1=présence de cellules tumorales positives pour NY-ESO-1 | n2=en:ighv4-34 positive | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr